Title | Author(s) | Issue date | ???itemlist.??? |
Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients | Makis, A. C.; Hatzimichael, E. C.; Mavridis, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Brucellosis in infant after familial outbreak | Makis, A. C.; Pappas, G.; Galanakis, E.; Haliasos, N.; Siamopoulou, A. | 24-Nov-2015 | - |
C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease | Makis, A. C.; Hatzimichael, E. C.; Stebbing, J.; Bourantas, K. L. | 24-Nov-2015 | - |
Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment | Makis, A. C.; Hatzimichael, E. C.; Kolios, G.; Bourantas, K. L. | 24-Nov-2015 | - |
The genomics of new drugs in sickle cell disease | Makis, A. C.; Hatzimichael, E. C.; Stebbing, J. | 24-Nov-2015 | - |
Incidence and other epidemiological characteristics of sudden cardiac death in northwest Greece | Goudevenos, J. A.; Papadimitriou, E. D.; Papathanasiou, A.; Makis, A. C.; Pappas, K.; Sideris, D. A. | 24-Nov-2015 | - |
Prolonged interferon-alpha-2b treatment of hairy cell leukemia patients | Bourantas, K. L.; Hatzimichael, E. C.; Makis, A. C.; Kapsali, E.; Tsiara, S.; Christou, L.; Seferiadis, K. | 24-Nov-2015 | - |
Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient | Makis, A. C.; Chaliasos, N.; Hatzimichael, E. C.; Bourantas, K. L. | 24-Nov-2015 | - |
The role of cytokines in sickle cell disease | Makis, A. C.; Hatzimichael, E. C.; Bourantas, K. L. | 24-Nov-2015 | - |
Serum beta-2-microglobulin, TNF-alpha and interleukins in myeloproliferative disorders | Bourantas, K. L.; Hatzimichael, E. C.; Makis, A. C.; Chaidos, A.; Kapsali, E. D.; Tsiara, S.; Mavridis, A. | 24-Nov-2015 | - |
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients | Sfagos, C.; Makis, A. C.; Chaidos, A.; Hatzimichael, E. C.; Dalamaga, A.; Kosma, K.; Bourantas, K. L. | 24-Nov-2015 | - |
Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis | Makis, A. C.; Galanakis, E.; Hatzimichael, E. C.; Papadopoulou, Z. L.; Siamopoulou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5 | Makis, A. C.; Tzoufi, M.; Kateri, M. D.; Bourantas, K. L.; Papadopoulou, Z. L. | 24-Nov-2015 | - |
Valproate-Induced Eosinophilia in Children With Epilepsy: Role of Interleukin-5 | Kateri, M.; Makis, A. C.; Tzoufi, M.; Bourantas, K. L.; Papadopoulou, Z. L. | 24-Nov-2015 | - |